Understanding urinary tract infections caused by resistant bacteria
Official title: Urinary Tract Infections Caused by Extended-spectrum Beta-lactamase-producing Enterobacteria: Management by General Practitioners in Bas-Rhin.
Run by University Hospital, Strasbourg, France · NCT06910878 · Data updated 2026-11-12
This study looks at how doctors in the Bas-Rhin region treat urinary tract infections caused by hard-to-treat bacteria to see if there are better ways to help patients.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 100 (estimated) |
| Sponsor | University Hospital, Strasbourg, France Academic / other |
| Locations | 1 site (Strasbourg) |
| Status | Recruiting |
| Started | October 24, 2024 |
| Main results expected | December 24, 2025 |
| Study ends | December 24, 2025 |
| Registry record updated | April 4, 2025 |
| Trial ID | NCT06910878 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18 and older with a confirmed Enterobacteriaceae urinary tract infection treated in a primary care setting.
✕Probably not a fit
Patients who do not have a urinary tract infection or those whose primary care physician does not agree to participate may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study focuses on urinary tract infections (UTIs) caused by extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBL-E), which are increasingly resistant to common antibiotics. It aims to analyze how general practitioners in the Bas-Rhin region manage these infections and identify potential improvements in treatment approaches. The study will involve adult patients diagnosed with ESBL-E UTIs in a primary care setting between June and December 2024, with data collected from their medical records and physician input.
Why it matters
Potential benefit: If successful, this study could lead to improved management strategies for UTIs caused by resistant bacteria, enhancing patient outcomes.
How similar studies have gone: While the specific approach of this study is observational and focused on a regional context, similar studies addressing antibiotic resistance in UTIs have shown promising results in improving treatment protocols.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adult (≥18 years old) * Subject with an Enterobacteriaceae urinary tract infection treated in a primary care setting for urinary tract infection between June 1, 2024 and December 31, 2024 * Subject not objecting, after being informed, to the reuse of their data for the purposes of this research. * The subject's primary care physician agreeing to participate in the study Exclusion Criteria: * Subject and/or their primary care physician having expressed their opposition to participating in the study * Subject under legal protection * Subject under guardianship or curatorship
Where it's running
-
Service de maladies infectieuses et tropicales - Hôpitaux Universitaires de Strasbourg
Strasbourg, France Recruiting
Study contacts
- Study coordinator: Yves HANSMANN, MD, PhD
- Email: yves.hansmann@chru-strasbourg.fr
- Phone: 33 3 69 55 09 78
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Gentamicin Irrigation and Suction Ureteral Access in Kidney Stone Surgery
This trial tests whether using gentamicin-containing irrigation fluid and a suction-enabled ureteral access sheath during retrograde intrarenal surgery (RIRS) can lower fever, SIRS, and sepsis after kidney stone treatment.
-
Gepotidacin in Breast Milk of Healthy Lactating Women
This study will test how gepotidacin behaves in the breast milk of healthy lactating women who are breastfeeding.
-
Post-Emergency Antibiotic Optimization for UTI
In people who come to the emergency department with a suspected urinary tract infection, this study looks at how doctors can adjust antibiotic therapy after urine culture results to use the right antibiotic and reduce overuse.
-
Prophylactic antibiotics to reduce post-procedure UTIs after urethral bulking
We’re testing whether giving a preventive antibiotic at the time of urethral bulking can lower the chance of a urinary tract infection after the procedure for women with stress or mixed urinary incontinence.
-
21-day comprehensive spa care for kidney and urinary conditions
This program will try a 21-day spa treatment with mineral water baths, drinking cures, exercise and diet for adults 40–70 who have chronic kidney or urinary problems to see if it improves symptoms and kidney health.
-
Testing single and multiple IV doses of JKN2501 in healthy Chinese adults
This test gives single and multiple intravenous doses of JKN2501 to healthy Chinese adults to see if it's safe and how the body processes it.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.